Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17302368 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
2 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Hepatocellular Carcinoma
Intervention: Drug: peginterferon alpha-2a  and ribavirin

Indicates status has not been verified in more than two years